Denali Therapeutics Inc. announced that its new drug Avlayah will soon be available on the US market after receiving regulatory approval.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
The main highlight of this medication is its once-weekly dosing frequency, which offers patients a more convenient treatment option.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Signs of Strength in U.S. Economy Power Stocks -- WSJ
Dow Jones•2026/09/30 16:20
Silver Price Forecast: XAG/USD remains vulnerable near $60
FXStreet•2026/09/30 15:27
BMO analyst: The cooling of inflation exceeded expectations
Chaincatcher•2026/09/30 15:27
Roche (RHHBY.US) BTK inhibitor submitted for listing
On September 30, Roche (RHHBY.US) announced that the U.S. FDA has accepted the New Drug Application (NDA) for its non-covalent BTK inhibitor, fenebrutinib.
智通财经•2026/09/30 15:26
Crypto prices
More
Bitcoin
BTC
$84,401.14
+1.48%
Ethereum
ETH
$2,690.74
+0.37%
Tether USDt
USDT
$0.9994
-0.03%
BNB
BNB
$769.53
+1.93%
XRP
XRP
$1.51
-0.46%
USDC
USDC
$1
+0.01%
Solana
SOL
$119.71
+1.08%
TRON
TRX
$0.3382
+1.06%
Zcash
ZEC
$1,449.49
+4.14%
Hyperliquid
HYPE
$88.07
+1.41%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now